NX Prenatal Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on February 10, 2025 - 12:30 GMT

NX Prenatal Announces Positive Clinical Data from Landmark Preterm Birth Diagnostic Study

Time2Prepare™ Test Demonstrates First-Trimester Capability to Identify High-Risk Pregnancies for Enhanced Medical Intervention BELLAIRE, TX, UNITED STATES, February 10, 2025 /⁨EINPresswire.com⁩/ -- NX Prenatal, a leading women’s healthcare company focused …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2024 - 11:00 GMT

NX Prenatal Supports PREBIC Publication Highlighting Importance of 'Early' Testing and Intervention for Pre-Term Birth

Publication Calls for New Biomarker Testing to Support Patient Identification to Facilitate Interventions as Early as the First Trimester BELLAIRE, TX, UNITED STATES, August 6, 2024 /⁨EINPresswire.com⁩/ -- The Preterm Birth International Collaborative …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 20, 2024 - 11:00 GMT

NX Prenatal Announces New Clinical Study Published in AJOG

Provides Strong Evidence Supporting the Time-to-Prepare Test’s Ability to Predict Pre-Term Birth in First Trimester Samples BELLAIRE, TX, USA, June 20, 2024 /⁨EINPresswire.com⁩/ -- NX Prenatal, a leading women’s healthcare company focused on the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 18, 2024 - 11:00 GMT

NX Prenatal Appoints Paul Kortschak to Serve as Chief Executive Officer

LOUISVILLE, KY, UNITED STATES, April 18, 2024 /⁨EINPresswire.com⁩/ -- NX Prenatal, a leading women’s healthcare company focused on the development of advanced prenatal diagnostic tests, proudly announces the appointment of Paul Kortschak as Chief …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2024 - 11:00 GMT

NX Prenatal Welcomes Scott Gleason as Chief Financial Officer

BELLAIRE, TX, UNITED STATES, April 2, 2024 /⁨EINPresswire.com⁩/ -- NX Prenatal, a leading women’s healthcare company focused on the development of advanced prenatal diagnostic tests, proudly announces the appointment of Scott Gleason as Chief Financial …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 16, 2023 - 13:26 GMT

NX Prenatal Announced as Founding Member of New Alliance for Prenatal Health Equity

LOUISVILLE, KY, UNITED STATES, February 16, 2023 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (“NX Prenatal”) today announced a partnership with the Louisville-based Health Equity Innovation Hub (the “Hub”) to establish a new Alliance for Prenatal Health …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 18, 2023 - 17:11 GMT

NX Prenatal Announces Addition of Dr. Robert Bonebrake to Strategic Advisory Board

LOUISVILLE, KY, USA, January 18, 2023 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (“NX Prenatal”) today announced that Robert G. Bonebrake, MD, FACOG has joined its Strategic Advisory Board. Dr. Bonebrake is a partner with Perinatal Associates at The …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 5, 2023 - 16:00 GMT

NX Prenatal Announces Breakthrough Findings for the Detection of Placenta Accreta

Pregnant Moms with Prior C-Sections or Other Surgical Procedures at Heightened Risk; No Current Blood Test Exists LOUISVILLE, KY, UNITED STATES, January 5, 2023 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (the “Company” or “NX Prenatal”) and its …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on November 1, 2022 - 17:00 GMT

NX Prenatal Named as an Awardee in Maternal-Fetal Immune Disorders QuickFire Challenge: Innovating for Health Equity

LOUISVILLE, KY, UNITED STATES, November 1, 2022 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. has been selected as an awardee of the Maternal-fetal Immune Disorders QuickFire Challenge: Innovating for Health Equity. Launched by Johnson & Johnson Innovation …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 1, 2021 - 15:29 GMT

NX Prenatal Announces Initiation of a Clinical Study for the Detection of Placenta Accreta

Pregnant Moms with Prior C-Sections or Other Surgical Procedures at Heightened Risk LOUISVILLE, KY, UNITED STATES, April 1, 2021 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (the “Company” or “NX Prenatal”), is pleased to announce it is a sponsor and …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 27, 2021 - 16:58 GMT

NX Prenatal Expands Leading Patent Position in Exosome-Based Liquid Biopsy Tests in Maternal- Fetal Medicine

LOUISVILLE, KY, UNITED STATES, January 27, 2021 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (“NX Prenatal”) today announced that it has achieved new patent issuances in both the United States and Europe for its exosome-based liquid biopsy tests for the early …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on October 26, 2020 - 16:00 GMT

NX Prenatal Announces Publication of First Trimester Exosome Liquid Biopsy Test Data for Preeclampsia Risk

HOUSTON, TX, UNITED STATES, October 26, 2020 /⁨EINPresswire.com⁩/ -- NX Prenatal Inc. (“NX Prenatal”) today announced the publication of new data demonstrating that exosome-associated protein biomarkers derived from first trimester maternal plasma are key …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...